Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
Comparative Risk of Metabolic Adverse Outcomes in Patients with Schizophrenia Spectrum Disorder Treated with Aripiprazole Versus Olanzapine: A Retrospective Cohort Study Using the Global TriNetX Network
Authored by
Cameron Asay
Drexel University College of Medicine, USA.
Kypros Dereschuk
Drexel University College of Medicine, USA.
Eduardo Espiridion
Drexel University College of Medicine, USA.